Celsius Holdings (CELH) jumped 12% Thursday after smashing Q2 revenue estimates, while Kimberly‑Clark (KMB) slipped 3% on a weaker guidance outlook.
And I checked the charts – CELH posted $317 million in revenue, beating analysts’ $287 million consensus by $30 million; KMB forecast $5.3 billion in FY24 sales, missing the $5.4 billion Wall Street target.
But the market reaction tells a deeper story.
For Celsius, the Reuters report highlighted a 45% surge in international demand, driven by new product launches in Europe.
Because the company raised its FY24 earnings per share (EPS) guidance to $1.18 from $0.94, analysts at Smart Glasses Detector Apps Tested upgraded their price target to $45, up from $38.
“Celsius is riding a wave of consumer health trends that could sustain double‑digit growth,” said Evercore analyst Maya Patel.
Kimberly‑Clark, on the other hand, cited a slowdown in personal care product sales, especially in emerging markets, and trimmed its FY24 EPS outlook to $9.45 from $9.80.
The stock fell despite a Bloomberg note that its dividend yield remains at 3.6% — a figure that income‑focused investors still love.
Pure panic.
In my experience trading, a 12% pop like CELH’s can erase weeks of risk, yet it also invites profit‑taking; KMB’s modest dip may be a buying opportunity for dividend hunters.
The Bottom Line
The Bottom Line
Both stocks sit in different corners of the market: Celsius is a high‑growth, volatility‑prone play, while Kimberly‑Clark offers stability and cash flow.
- Celsius Q2 revenue: $317 million (beat)
- KMB FY24 EPS guidance: $9.45 (down)
- CELH price target: $45 (upgraded)
- KMB dividend yield: 3.6%
And the choice hinges on your risk tolerance.
So decide whether you want a rocket‑fueled growth story or a steady dividend payer.
Trade Smarter with gnewsx Investing
The market waits for no one. Get real-time stock analysis, earnings breakdowns, and expert market insights. Make better investment decisions at gnewsx.com — your ultimate edge on Wall Street.
